Literature DB >> 2823697

Polysaccharides as antiviral agents: antiviral activity of carrageenan.

M E González1, B Alarcón, L Carrasco.   

Abstract

A number of polysaccharides showed good antiviral activity against several animal viruses. At 5 micrograms/ml, carrageenan prevented the cell monolayer from destruction by herpes simplex virus type 1 (HSV-1) growth. At 10 micrograms/ml, carrageenan reduced the formation of new infectious HSV-1 by almost five logs. No cytotoxic effects were detected with concentrations of carrageenan up to 200 micrograms/ml. When 10 micrograms of carrageenan per ml was added at the beginning of HSV-1 infection of HeLa cells, there was potent inhibition of viral protein synthesis, and the cells continued synthesizing cellular proteins. This did not occur if carrageenan was added 1 h after HSV-1 infection. The use of [35S]methionine-labeled virions to analyze the entry of HSV-1 or Semliki Forest virions into cells indicated that carrageenan had no effect on virus attachment or virus entry. Moreover, carrageenan did not block the early permeabilization of cells to the toxic protein alpha-sarcin. These results suggest that this sulfated polysaccharide inhibits a step in virus replication subsequent to viral internalization but prior to the onset of late viral protein synthesis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2823697      PMCID: PMC174948          DOI: 10.1128/AAC.31.9.1388

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  23 in total

1.  THE BASIS FOR THE SIZE DIFFERENCES IN PLAQUES PRODUCED BY VARIANTS OF ENCEPHALOMYOCARDITIS (EMC) VIRUS.

Authors:  H LIEBHABER; K K TAKEMOTO
Journal:  Virology       Date:  1963-08       Impact factor: 3.616

2.  Heterogeneity of Coxsackie B4 virus: two kinds of particles which differ in antibody sensitivity, growth rate, and plaque size.

Authors:  P W CHOPPIN; H J EGGERS
Journal:  Virology       Date:  1962-11       Impact factor: 3.616

3.  Virus-polysaccharide interactions. II. Enhancement of plague formation and the detection of variants of poliovirus with dextran sulfate.

Authors:  K K TAKEMOTO; H LIEBHABER
Journal:  Virology       Date:  1962-07       Impact factor: 3.616

4.  Virus-polysaccharide interactions. I. An agar polysaccharide determining plaque morphology of EMC virus.

Authors:  K K TAKEMOTO; H LIEBHABER
Journal:  Virology       Date:  1961-08       Impact factor: 3.616

5.  Oral heparin results in the appearance of heparin fragments in the plasma of rats.

Authors:  A K Larsen; D P Lund; R Langer; J Folkman
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

6.  Screening for new compounds with antiherpes activity.

Authors:  B Alarcón; J C Lacal; J M Fernández-Sousa; L Carrasco
Journal:  Antiviral Res       Date:  1984-10       Impact factor: 5.970

7.  Viral infection permeabilizes mammalian cells to protein toxins.

Authors:  C Fernández-Puentes; L Carrasco
Journal:  Cell       Date:  1980-07       Impact factor: 41.582

8.  Modification of membrane permeability during Semliki Forest virus infection.

Authors:  A Muñoz; J L Castrillo; L Carrasco
Journal:  Virology       Date:  1985-10-30       Impact factor: 3.616

9.  Prolongation of scrapie incubation period by an injection of dextran sulphate 500 within the month before or after infection.

Authors:  C F Farquhar; A G Dickinson
Journal:  J Gen Virol       Date:  1986-03       Impact factor: 3.891

10.  Adenovirus-induced release of epidermal growth factor and pseudomonas toxin into the cytosol of KB cells during receptor-mediated endocytosis.

Authors:  D J FitzGerald; R Padmanabhan; I Pastan; M C Willingham
Journal:  Cell       Date:  1983-02       Impact factor: 66.850

View more
  47 in total

Review 1.  Role of heparan sulfate in sexually transmitted infections.

Authors:  Vaibhav Tiwari; Erika Maus; Ira M Sigar; Kyle H Ramsey; Deepak Shukla
Journal:  Glycobiology       Date:  2012-07-06       Impact factor: 4.313

2.  Novel Polyanions Inhibiting Replication of Influenza Viruses.

Authors:  Justyna Ciejka; Aleksandra Milewska; Magdalena Wytrwal; Jacek Wojarski; Anna Golda; Marek Ochman; Maria Nowakowska; Krzysztof Szczubialka; Krzysztof Pyrc
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191

3.  Pharmaceutically Acceptable Carboxylic Acid-Terminated Polymers Show Activity and Selectivity against HSV-1 and HSV-2 and Synergy with Antiviral Drugs.

Authors:  Tejabhiram Yadavalli; Sudipta Mallick; Pratikkumar Patel; Raghuram Koganti; Deepak Shukla; Abhijit A Date
Journal:  ACS Infect Dis       Date:  2020-10-20       Impact factor: 5.084

4.  Algae as promising organisms for environment and health.

Authors:  Emad A Shalaby
Journal:  Plant Signal Behav       Date:  2011-09

5.  Antiviral bioactivity of renewable polysaccharides against Varicella Zoster.

Authors:  Eiman Abu-Galiyun; Mahmoud Huleihel; Oshrat Levy-Ontman
Journal:  Cell Cycle       Date:  2019-11-14       Impact factor: 4.534

6.  Enhancement of enterovirus infectivity in vitro by pretreating host cell monolayers with the cationic polymer polyethyleneimine.

Authors:  D R Preston; G Bitton; S R Farrah
Journal:  Appl Environ Microbiol       Date:  1990-01       Impact factor: 4.792

7.  6-(3,4-Dichlorophenoxy)-3-(ethylthio)-2-pyridincarbonitrile inhibits poliovirus uncoating.

Authors:  M E González; M J Almela; M Yacout; L Carrasco
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

8.  Entry of feline calicivirus is dependent on clathrin-mediated endocytosis and acidification in endosomes.

Authors:  Amanda D Stuart; T David K Brown
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

9.  Virucidal activity of polysaccharide extracts from four algal species against herpes simplex virus.

Authors:  Emma A Harden; Ruth Falshaw; Susan M Carnachan; Earl R Kern; Mark N Prichard
Journal:  Antiviral Res       Date:  2009-07-01       Impact factor: 5.970

10.  Antiviral activities of extracts from Hong Kong seaweeds.

Authors:  Hui Wang; Engchoon Vincent Ooi; Put O Ang
Journal:  J Zhejiang Univ Sci B       Date:  2008-12       Impact factor: 3.066

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.